-
10793-5A tyrphostin compound that inhibits nerve growth factor (NGF)-dependent TrkA tyrosine phosphorylation in PC-12 cells (IC50 = ~40&muM), HER2-ErbB2 kinase in several breast and ovarian cancer cell lines (IC50 = ~0.5 &muM), and the VEGF receptor FLK1
-
10793-50A tyrphostin compound that inhibits nerve growth factor (NGF)-dependent TrkA tyrosine phosphorylation in PC-12 cells (IC50 = ~40&muM), HER2-ErbB2 kinase in several breast and ovarian cancer cell lines (IC50 = ~0.5 &muM), and the VEGF receptor FLK1
-
10010313-10AG-99 is an inhibitor of EGF receptor kinase with an IC50 value of 10 µM in the human epidermoid carcinoma cell line A431.
-
10010313-25AG-99 is an inhibitor of EGF receptor kinase with an IC50 value of 10 µM in the human epidermoid carcinoma cell line A431.
-
10010313-5AG-99 is an inhibitor of EGF receptor kinase with an IC50 value of 10 µM in the human epidermoid carcinoma cell line A431.
-
10010313-50AG-99 is an inhibitor of EGF receptor kinase with an IC50 value of 10 µM in the human epidermoid carcinoma cell line A431.
-
17259-1A tyrphostin that targets transforming Bcr-Abl fusion proteins (p185Bcr-Abl, p210Bcr-Abl, as well as normal c-Abl (IC<sub>50</sub>s = 4.3, 1, and 7.1 µM, respectively, for human proteins) also inhibits EGFR (IC<sub>50</sub> = 0.25 µM).
-
17259-10A tyrphostin that targets transforming Bcr-Abl fusion proteins (p185Bcr-Abl, p210Bcr-Abl, as well as normal c-Abl (IC<sub>50</sub>s = 4.3, 1, and 7.1 µM, respectively, for human proteins) also inhibits EGFR (IC<sub>50</sub> = 0.25 µM).
-
17259-5A tyrphostin that targets transforming Bcr-Abl fusion proteins (p185Bcr-Abl, p210Bcr-Abl, as well as normal c-Abl (IC<sub>50</sub>s = 4.3, 1, and 7.1 µM, respectively, for human proteins) also inhibits EGFR (IC<sub>50</sub> = 0.25 µM).
-
-
-
AB0014.SIZE.250gThe Bio Basic Agarose B, Low EEO with a composition of Application: For Laboratory Research Use Only